These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Physiological bases of the use of ACTH and cortisone]. LAMMERS L Z Haut Geschlechtskr; 1954 May; 16(9):257-63. PubMed ID: 13179691 [No Abstract] [Full Text] [Related]
43. [Clinical application of ACTH and cortisone]. MIEDZINSKI F Przegl Dermatol; 1954; 4(1):65-75. PubMed ID: 13177745 [No Abstract] [Full Text] [Related]
44. [Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients]. Béal JL; Freysz M; Honnart D; Wilkening M Therapie; 1983; 38(5):569-71. PubMed ID: 6322376 [No Abstract] [Full Text] [Related]
45. [Clinical experiences with cortisone and ACTH in dermatology]. TAPPEINER S Wien Klin Wochenschr; 1954 Apr; 66(14):237-41. PubMed ID: 13169768 [No Abstract] [Full Text] [Related]
46. [Tetracosactid (Synacthen) as a therapeutic alternative in uveitis and other chronic inflammations of the eye]. Fricke HJ; Heydenreich A; Thiel U; Schröder D Klin Monbl Augenheilkd; 1983 Jul; 183(1):10-6. PubMed ID: 6310203 [No Abstract] [Full Text] [Related]
47. [Hypersensitivity to tetracosactide]. Ligumski M; Kletter-Chemo D; Penchas S Harefuah; 1977 Feb; 92(4):169-70. PubMed ID: 191336 [No Abstract] [Full Text] [Related]
48. [Tetracosactide in the acute phase of cerebrovascular accidents]. Cornaert P Lille Med; 1980; 25(7):384-6. PubMed ID: 6253756 [No Abstract] [Full Text] [Related]
49. Uses and abuses of ACTH and cortisone: dermatology. ROBINSON RC Md State Med J; 1957 Jan; 6(1):28-31. PubMed ID: 13407189 [No Abstract] [Full Text] [Related]
50. Hyperkalemia as a late side effect of prolonged adrenocorticotropic hormone therapy for infantile spasms. Zeharia A; Levy Y; Rachmel A; Nitzan M; Steinherz R Helv Paediatr Acta; 1987 Jun; 42(5-6):433-6. PubMed ID: 3136101 [TBL] [Abstract][Full Text] [Related]
51. Adrenal-independent, anti-shock effect of ACTH-(1-24) in rats. Bertolini A; Guarini S; Ferrari W Eur J Pharmacol; 1986 Apr; 122(3):387-8. PubMed ID: 3011452 [No Abstract] [Full Text] [Related]
52. [Synacthen therapy and prostatic carcinoma?]. Staehler W; Ziegler H Med Welt; 1975 Apr; 26(14):682. PubMed ID: 169454 [No Abstract] [Full Text] [Related]
53. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide]. Cret L; David M; Macabéo V; Frédérich A; Jeune M Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427 [No Abstract] [Full Text] [Related]
54. Treatment of cerebral infarcts with anti-oedema agents. Guibert F; Laporte A; Bidabe AM; Henry P; Caille JM J Neuroradiol; 1979; 6(1):65-76. PubMed ID: 225455 [No Abstract] [Full Text] [Related]
55. ACTH and cortisone in diseases of the skin. LEVER WF N Engl J Med; 1951 Sep; 245(10):359-63. PubMed ID: 14863589 [No Abstract] [Full Text] [Related]
56. Diverticular disease treated with corticotrophin. Steer C J R Coll Gen Pract; 1985 Nov; 35(280):532-3. PubMed ID: 3001302 [TBL] [Abstract][Full Text] [Related]